A Correlation Between Gene Transcriptional Activity and Cerebral Glucose Metabolism in Alzheimer’s Disease-Affected Neocortex: Cause or Effect?
Our laboratory has measured mRNA pool sizes in neocortex afflicted with Alzheimer’s disease (AD). We have observed a repression of gene expression in the temporal and parietal regions compared to age-matched control neocortex. These changes in messenger RNA pool size closely parallel the observed alterations in local cerebral metabolic rates for glucose (LCMR-g), as detected by positron emission tomography (PET). For example, deficits in both gene transcription and glucose metabolism appear to be the greatest in AD-affected superior temporal neocortex (Brodmann area 22) but are less apparent in the primary visual cortex (Brodmann area 17) or in the cerebellum. The unresolved question is whether changes in gene expression are the cause or effect of altered glucose metabolism. However, the non-random reductions in the pool size for certain neocortical mRNAs argue in favour of altered gene expression as the primary event.
KeywordsPositron Emission Tomography Brodmann Area Neurofibrillary Degeneration Brain Energy Metabolism Associative Brain Region
Unable to display preview. Download preview PDF.
- Chin S. S. M. and Liem R. K., 1987, Neurofilaments: A Review and an Update. in: “Alterations in the Neuronal Cytoskeieton in Alzheimer’s Disease, Advances in Behavioral Biology 34”, G. Perry, ed., Plenum Press, New York.Google Scholar
- Hoyer, S., 1990, Brain energy metabolism and its significance for Alzheimer’s disease. Abstract 33. Second International Conference on Alzheimer’s Disease, Neurobiol. Aging, 11: 260.Google Scholar
- Kittur, S., Hoh, J., Kawas, C., Tourtellotte, W., Marksberry, W., and Ad-ler, W., 1990, Neurofilament gene expression in Alzheimer’s disease. Abstract 135. Second International Conference on Alzheimer’s Disease, Neurobiol. Aging, 11:285.Google Scholar
- Mazziotta, J.C. and Phelps, M. E., 1990, The pathophysiology of Alzheimer’s disease as identified with PET. Abstract 36. Second International Conference on Alzheimer’s Disease, Neurobiol. Aging, 11:261.Google Scholar
- Montaldi, D., Brooks, D. N., McColl., J. H., Wyper, D., Patterson, J., Barron, E. and McCulloch J., 1990, Measurements of regional cerebral blood flow and cognitive performance in Alzheimer’s disease, J. Neurol., 53:33.Google Scholar
- Morrison, M. R., and Griffin, W. S. T., 1981, The isolation and in vitro translation of undegraded messenger RNAs from human post-mortem brain, Analyt. Biochem., 113:318.Google Scholar
- Taylor G. R., Carte, G. I., Grow, T. J., Johnson, J. A., Fairbairn, A. F., Perry, E. K. and Perry, R. H., 1986, Recovery and measurement of specific RNA species from post-mortem brain tissue: A general reduction in Alzheimer’s disease detected by molecular hybridization, Exp. Mol. Pathol., 44: 111.PubMedCrossRefGoogle Scholar
- Terry, R. D., 1983, Cortical morphometry in Alzheimer’s disease, in: “Biological Aspects of Alzheimer’s Disease,” R. Katzman, ed., Cold Spring Harbor Laboratory, New York.Google Scholar